374808-04-5

Basic information

• Product Name: Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-[3-(4-nitrophenyl)-1-oxopropyl]-
• CAS NO: 374808-04-5
• Molecular Formula: C28H31N3O4
• Molecular Weight: 473.572
• Mol File: 374808-04-5.mol

Chemical Properties

• CAS DataBase Reference: Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-[3-(4-nitrophenyl)-1-oxopropyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-[3-(4-nitrophenyl)-1-oxopropyl]-(374808-04-5)
• EPA Substance Registry System: Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-[3-(4-nitrophenyl)-1-oxopropyl]-(374808-04-5)

Safety Data

• Hazardous Substances Data: 374808-04-5(Hazardous Substances Data)

Upstream product

• 79-37-8 oxalyl dichloride 
• 60703-69-7 1-[2-(diphenylmethoxy)ethyl]piperazine 
• 16642-79-8 3-(4-nitrophenyl)propionic acid 
• 107324-93-6 3-(p-nitrophenyl)propanoyl chloride 

Downstream Products

• 127139-25-7 1-[2-[bis(phenyl)methoxy]ethyl]-4-(3-(4-aminophenyl)propyl)piperazine 
• 374808-69-2 thioacetic acid S-[10-(4-{3-[(4-(2-benzhydryloxyethyl)piperazin-1-yl)propyl]phenyl}carbamoyl)decyl] ester 
• 374808-68-1 11-bromoundecanoic acid (4-{3-[4-(2-benzhydryloxyethyl)piperazin-1-yl]propyl}phenyl)amide 
• 616874-65-8 thioacetic acid (S)-2-{2-[(4-{3-[4-(2-benzhydryloxyethyl)piperazin-1-yl]propyl}phenylcarbamoyl)methoxy]ethoxy}ethyl ester 
• 616874-64-7 N-(4-{3-[4-(2-benzhydryloxyethyl)piperazin-1-yl]propyl}phenyl)-2-[2-(2-cloroethoxy)ethoxy]acetamide 

Relevant articles and documents

Linker arms for nanocrystals and compounds thereof

A nanocrystal compound comprising: a nanocrystal, and attached thereto a compound of the following formula: n is 0 or an integer from 1 to 48; X and Z are independently O, NH, N—R, S, CH2, CO, COHN, NHCO, SO, SO2NH, NHSO2, carbamate and thio carbamate; R is alkyl or aryl; r is 0 or an integer from 1 to 15; and wherein S is the attachment point to a nanocrystal compound. The nanocrystal compounds of the present invention are useful fluorescent labels.

The design and synthesis of novel derivatives of the dopamine uptake inhibitors GBR 12909 and GBR 12935. High-affinity dopaminergic ligands for conjugation with highly fluorescent cadmium selenide/zinc sulfide core/shell nanocrystals

There is a growing demand for compounds with very high affinities for the dopamine transporter protein (DAT) that can be conjugated to fluorescent markers such as cadmium selenide/zinc sulfide core/shell nanocrystals. This paper describes the design and synthesis of two derivatives of the DAT antagonists GBR 12935 and GBR 12909. These compounds have a high biological affinity for DAT and may be conjugated to nanocrystals via a thiol linkage without a significant reduction in their biological activity. Such conjugates may be used in fluorescent imaging studies.